We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy.
- Authors
LoConte, Noelle K; Smith, Maureen; Alberti, Dona; Bozeman, Jeffrey; Cleary, James F; Setala, Ashley N; Wodtke, Geoff; Wilding, George; Holen, Kyle D
- Abstract
There are no clear predictors clinicians can use to determine who is more likely to experience dose-limiting toxicity (DLT) in phase I chemotherapy clinical trials. Many providers are reluctant to refer older adults to phase I trials because of concerns about the development of toxicity. The goal of this study was to identify clinical and nonclinical factors which were associated with the development of DLT in phase I studies.
- Publication
Cancer chemotherapy and pharmacology, 2010, Vol 65, Issue 4, p775
- ISSN
1432-0843
- Publication type
Journal Article
- DOI
10.1007/s00280-009-1084-8